Consulting portfolio is a venn between 3 spheres of Introspection (incl strategy, deep futures and systems thinking), Innovation (incl bio-tech, translation, SIT policy) and Impact.
Functional expertise in strategy and policy development, new product development, fundraising and business development, commercialisation, due diligence, capability building, outcomes monitoring and reporting
Strengths:
Markets: NZ, UK, India, US, Singapore
Sectors: Deep Tech (incl. Biotech, Healthtech, Agritech, Medtech), Pharmaceuticals, Public sector, Financial Services
Stage : Conception, Research Commercialisation and Innovation Strategy, Systems Transformation
Clients/ Projects:
– MBIE NZ Institute of Advanced Technologies on establishment and synthetic biology
– Malaghan Institute of Medical Research on 2030 strategy development, CAR-T cell Phase 2 clinical trial fundraising strategy with philanthropists, government funding strategy and reporting, and translation research capacity building
– NZ RNA Platform on benchmarking, translation research capability building, developing flagship project/s and reporting
– Kiwinet on developing commercial aspiration and core capability through the Emerging Innovator Programme
– ImpactLab on mapping impact investing and housing markets strategy, new product and client development
– BioPacific Partners on health and biotech innovation partnerships with global MNCs and government
